Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

U.S. researchers divulge new immunotherapeutic constructs for cancer

Feb. 10, 2021

Shouyao Holdings (Beijing) identifies new Ret inhibitors

Feb. 10, 2021

Teon Therapeutics patents new adenosine A2A receptor antagonists

Feb. 10, 2021

NSC-765690 and NSC-765599 show antitumor activity against NCI60 human tumor cell lines

Feb. 10, 2021

SorLA identified as a target in anti-HER2-resistant HER2-positive breast cancer

Feb. 10, 2021

European Commission approves Inrebic for newly diagnosed and previously treated myelofibrosis

Feb. 9, 2021

FDA clears Catapult's IND for phase I trial of CAP-100 in CLL

Feb. 9, 2021

Study identifies a transcriptional feedback loop regulating fatty acid synthesis in EAC

Feb. 9, 2021

Reduction of NK-activating ligand NKG2DL contributes to immune scape in SCLC and neuroblastoma

Feb. 9, 2021

GB005 identifies new BTK inhibitors

Feb. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...